Two novel trinuclear oxamato-bridged thiosemicarbazone complexes, [Cu(obte)] 2 Cd(DMF) 2 (2) and [Cu(obte)] 2 Mn(DMF) 2 (3) (H 2 obte = N-(2-benzaldehyde) oxamic acid ethyl ester thiosemicarbazone (1); DMF = dimethylformamide), have been synthesized and characterized by elemental analysis, IR spectroscopy, thermogravimetric analysis (TGA) and single-crystal X-ray diffraction. Complexes 2 and 3 are isostructural, displaying a trinuclear structure. The luminescence properties of complexes 2 and 3 were investigated in the solid state at room temperature. The ligand 1 and its complex 2 have been evaluated for their antitumor activities against K562 cells.
Introduction
Heterometallic complexes have been of considerable interest in recent years because of their important role in biochemistry and material science [1 -3] . To obtain heterometallic complexes, a successful strategy is the "complex as ligand" approach, i. e., utilizing a metal complex as a ligand to coordinate an appropriate additional metal ion [4, 5] . Along this line, the use of mononuclear oxamidato complexes as ligands toward other metal ions constitutes a step towards high-nuclearity metal complexes [6 -10] .
Thiosemicarbazones have been extensively studied because they have a wide range of actual or potential medical applications which include notably antiparasital [11] , antitumor [12, 13] and antibacterial activity [14] . Many thiosemicarbazones, such as Marboran or Triapine, are already used in medical practice. Their mechanism of action is still controversial in many respects, but it is known that heterocyclic thiosemicarbazones act by inhibiting ribonucleotide reductase, a key enzyme in the biosynthesis of DNA precursors [15] . In general, thiosemicarbazones are obtained by condensation of the corresponding thiosemicarbazide with aldehydes or ketones. They show a wide range of biological activity depending on the parent aldehyde or ketone. Earlier reports on N(4)-substituted thiosemicarbazones have concluded that the presence of bulky groups at the N(4) position of the thiosemicarbazone moiety greatly enhances biological activity [16 -18] .
For the purpose of construction of heterometallic coordination polymers with novel structure and biological activity, we have synthesized a new thiosemicarbazone ligand as an oxamato bridge using N-(2-benzaldehyde) oxamic acid ethyl ester (1) 
Experimental Section

Materials
All chemicals and solvents were of analytical grade and used as commercially available. N-(2-Benzaldehyde) oxamic acid ethyl ester was synthesized according to the literature [19] . The syntheses of 1, 2 and 3 were carried out as shown in Scheme 1.
Physical measurements
Elemental analyses for C, H and N were carried out on a Perkin-Elmer 2400II analyzer. The infrared spectra were recorded on an Avater-360 spectrometer using KBr pellets in a range of 400 ∼ 4000 cm −1 . Thermogravimetric analysis was carried out on an TGA/SDTA851 analyzer in a nitrogen atmosphere, and the complexes were heated to 1000 • C at a heating rate of 10 • C min −1 . The fluorescence spectra were measured on a F-7000 Fluorometer.
Synthesis of the ligand precursor EtH 2 obte (1)
The ligand was synthesized by refluxing a solution of N- (2- 
Synthesis of [Cu(obte)] 2 Cd(DMF) 2 (2)
An aqueous solution (10 mL) of Na[Cu(obte)]·H 2 O (0.071 g, 0.2 mmol) was added to a solution of Cd(NO 3 ) 2 ·4H 2 O (0.031 g, 0.1 mmol) in DMF (10 mL). The mixture was stirred for two hours to yield a pale-green solution. The solution was filtered, and the filtrate was left unperturbed to allow the slow evaporation of the solvent in air. Needle-shaped purple X-ray-quality single crystals of complex 2 were obtained after several days. Yield: 55 % based on the initial Cd(NO 3 
Synthesis of [Cu(obte)] 2 Mn(DMF) 2 (3)
The procedure was the same as that used for 2 except that Cd(NO 3 
Crystal structure determinations
The single crystals used for data collection were mounted on a Bruker Smart APEX diffractometer with a CCD detector using graphite monochromated MoK α radiation (λ = 0.71073Å). Lorentz and polarization corrections were applied to the intensity data, and an absorption correction was performed using the program SADABS [20] . The crystal structure was solved using SHELXTL and refined by fullmatrix least-squares techniques [21] . The positions of hydrogen atoms were calculated and included in the final cycles of refinement in a riding model along with the attached carbon atoms. Crystal data and numbers pertinent to data collection and structure refinement are given in Table 1 . Selected bond lengths and angles are given in Table 2 .
CCDC 724013 (1), 738488 (2) and 724014 (3) contain the supplementary crystallographic data for this paper. This data can be obtained, free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.com.ac.uk/data request/cif.
Antitumor experiments
The antitumor activity was investigated in cell line K562 (a human leucocythemia cancer cell line purchased from the Institute of Biochemistry and Cell Biology, SIBS, CAS).
Cells were cultured in RPMI-1640 medium supplemented with 10 % FBS, 100 U mL −1 of penicillin, 100 µg (200 µL per well) of streptomycin at 37 • C in humid air atmosphere containing 5 % CO 2 . Cell cytotoxicity was assessed by the MTT assay. Briefly, cells were placed into a 96-well plate (5 × 10 3 cells per well). The next day compounds at various concentrations (10, 30, 50 µmol mL −1 ) diluted in culture medium were added to the wells (100 µL per well). 24 h later, 20 µL of MTT (1 mg mL −1 MTT in FBS) was added, and the cells were incubated for a further 4 h. 150 µL of DMSO was added to each culture to dissolve the MTT crystals. The MTT-formazan product dissolved in DMSO was estimated by measuring absorbance at 570 nm with a micro plate reader. Then the inhibitory percentage of each compound at various concentrations was calculated, and the IC 50 (50 % inhibitory concentration) value was determined [22] .
Results and Discussion
Crystal structures of 1, 2 and 3
The ligand precursor 1 crystallizes in the monoclinic space group P2 1 /n with Z = 4. The molecular structure with the atomic numbering scheme is given in Fig. 1 , and selected bond lengths and angles are listed in Table 2 . The thiosemicarbazone skeleton comprising the atoms N3, N2, C1, S1 and N1 is practically planar (maximum deviation of −0.0086Å). The dihedral angle formed between the plane of the thiosemicarbazone and the phenyl ring is 0.47(8) • . 
91.8(8) O1-Cu1-S1 92.0(1) N3-Cu1-S1
86.9(1) N3-Cu1-S1 87.0(1) N4-Cu1-S1
177.4(9) N4-Cu1-S1 177.7(1) a Symmetry codes for 2: #1 −x, y, −z + 1/2; for 3, #1 −x + 1, y,
The C1-S1 (1.677(3)Å), C1-N2 (1.341(3)Å), N2-N3 (1.380(3)Å), and C2-N3 (1.275(3)Å) bond lengths are comparable with those of related compounds [23, 24] . The distances indicate that there is some electron delocalization in the thiosemicarbazide side chain. The C2-N3 distance (1.275(3)Å) is appreciably close to that of a C=N double bond (1.28Å), confirming the azomethine bond formation. The C9-C10 distance (1.526(4)Å]) is comparable with the data found in the literature (1.518(7)Å [25] ). Complexes 2 and 3 are isostructural crystallizing in the monoclinic space group C2/c with Z = 4. They exhibit crystallographical 2 (C 2 ) symmetry. The following discussion is restricted mainly to the Cd(II) com- Fig. 1 (color online) . Crystal structure of ligand 1 with the atomic numbering scheme adopted. Hydrogen atoms are omitted for clarity. Fig. 2 (color online) . Crystal structure of complex 2 with the atomic numbering scheme adopted. Hydrogen atoms are omitted for clarity. plex 2. The molecular structure of the complex 2 along with the atomic numbering scheme is given in Fig. 2 . Selected bond lengths and angles of 2 and 3 are listed in Table 2 .
Complex 2 consists of a heterotrinuclear unit Cu II Cd II Cu II and two DMF molecules. The Cd(II) ion is in a distorted octahedral coordination geometry, with four oxygen atoms from oxamato groups, and two oxygen atoms from two DMF molecules. The lengths of the Cd-O bonds range from 2.228(3) to 2.293(2)Å with the Cd-O(DMF) bond length being 2.228(3)Å. As can be seen in Table 2 , the Cd(II)-O bond lengths are slightly longer then the respective Mn(II)-O values. This is consistent with the larger ionic radius for hexa-coordinate Cd(II) with respect to hexa-coodinate high-spin Mn(II) [26] .
The Cd(II) ion is connected to the Cu(II) ions via the oxygen atoms of the oxamato ligand. The Cu(II) ion is in a distorted square-planar geometry with a CuN 2 OS surrounding. It is coordinated by one oxygen atom, two nitrogen atoms and one sulfur atom from oxamidate bridges. The Cu· · ·Cd distance through the oxamido bridge is 5.538Å.
Structurally there are a few significant differences between the ligand 1 and the novel cadmium(II) complex 2. The C-S bond distance has been increased from 1.677 (3) 
Thermogravimetric analysis
The TGA curves of complexes 2 and 3 are shown in Fig. 3 . The curve of 2 suggests that the weight loss in the range from 199 to 296 • C is 16 %, corresponding to the loss of two DMF molecules (calcd. weight continuously from 325 • C, indicating that the main structure collapses. The decomposition products were identified as MnO and CuO. The observed weight (24.0 %) was comparable with the calculated value (26.8 %).
Luminescence properties
The luminescence properties of 1, 2 and 3 were studied in the solid state at room temperature. As indicated in Fig. 4 , 1 exhibits a main emission peak at 380 nm upon excitation at 250 nm. This could be attributed to the benzaldehyde thiosemicarbazone group. Complexes 2 and 3 show luminescent emission maxima at 317, 359 nm (2) and 317, 360 nm (3) for the excitation Fig. 4 (color online) . Photoinduced emission spectra of 1, 2 and 3 in the solid state at room temperature. wavelength of 255 nm, it may be tentatively ascribed to ligand-to-metal charge transfer (LMCT). The intensity of the charge transfer band is increased with a pronounced red shift.
Antitumor activity
The Schiff base ligand 1, the mononuclear precursor Na[Cu(obte)] and the complex 2 were studied for their antitumor inhibitory effect at various concentrations (10, 30 , 50 µmol mL −1 ). The results are presented in Fig. 5 . Along with the increase of the concentration of compounds, their inhibitory effect against K562 is enhanced. It is clear from the data that the Schiff base ligand 1 shows less inhibitory effect for K562 than the metal compounds, and complex 2 shows the strongest inhibition, confirming that the antitumor activity of thiosemicarbazones can be enhanced by the linkage to metal ions.
